Literature DB >> 310743

The effect of levamisole on E-rosette formation by trypsinized lymphocytes.

R Lomnitzer, A R Rabson.   

Abstract

Normal lymphocytes treated with trypsin lost their ability to form normal numbers of rosettes with sheep red blood cells. The recovery in E-rosette forming capacity of trypsinized cells was considerably augmented when the cells were incubated in the presence of a wide range of concentrations of the immunostimulatory drug, levamisole. Substantial recovery of rosette-forming ability was seen 2 hr after incubation of trypsinized cells with levamisole.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 310743      PMCID: PMC1537449     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  15 in total

1.  Effect of levamisole on E-rosette-forming cells in vivo and in vitro in Hodgkin's disease.

Authors:  B Ramot; M Biniaminov; C Shoham; E Rosenthal
Journal:  N Engl J Med       Date:  1976-04-08       Impact factor: 91.245

Review 2.  Levamisole in the modulation of the immune response: the current experimental and clinical state.

Authors:  J Symoens; M Rosenthal
Journal:  J Reticuloendothel Soc       Date:  1977-03

3.  Modulation of human T lymphocyte rosette formation by autonomic agonists and cyclic nucleotides.

Authors:  M H Grieco; I Siegel; Z Goel
Journal:  J Allergy Clin Immunol       Date:  1976-07       Impact factor: 10.793

4.  The effects of azathioprine and levamisole on rosette-forming cells of healthy subjects and cancer patients.

Authors:  H Verhaegen; W De Cock; J De Cree
Journal:  Clin Exp Immunol       Date:  1977-08       Impact factor: 4.330

5.  Effects of levamisole on human monocyte function and immunoprotein receptors.

Authors:  M E Schmidt; S D Douglas
Journal:  Clin Immunol Immunopathol       Date:  1976-11

6.  Levamisole increases activated T lymphocytes.

Authors:  M Rosenthal
Journal:  Lancet       Date:  1977-09-24       Impact factor: 79.321

7.  Peripheral blood lymphocyte populations in chronic liver disease.

Authors:  H C Thomas; M Freni; J Sanchez-Tapias; D de Villiers; S Jain; S Sherlock
Journal:  Clin Exp Immunol       Date:  1976-11       Impact factor: 4.330

8.  Mechanisms responsible for defective human T-lymphocyte sheep erythrocyte rosette function associated with hepatitis B virus infections.

Authors:  F V Chisari; J A Routenberg; T S Edgington
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

9.  Levamisole and human lymphocyte surface markers.

Authors:  J Wybran; A Govaerts
Journal:  Clin Exp Immunol       Date:  1977-02       Impact factor: 4.330

10.  Relationship between E receptors and a T-specific surface antigen on human T cells.

Authors:  C Gattringer; G Wick
Journal:  Immunology       Date:  1977-02       Impact factor: 7.397

View more
  2 in total

1.  Detection of human T-lymphocyte receptor for sheep erythrocytes in immunoregulatory alpha-globulin.

Authors:  C C Musatti; S Daher; L A Bernd; N F Mendes
Journal:  J Clin Immunol       Date:  1983-10       Impact factor: 8.317

2.  Pharmacokinetics of levamisole in healthy subjects and cancer patients.

Authors:  M Luyckx; F Rousseau; M Cazin; C Brunet; J C Cazin; J M Haguenoer; B Devulder; I Lesieur; D Lesieur; P Gosselin; L Adenis; P Cappelaere; A Demaille
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1982 Oct-Dec       Impact factor: 2.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.